Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continued Access to Darunavir/Ritonavir in Pediatric HIV-1
NCT01138605Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2010
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Janssen Pharmaceutical. Started Oct 2010; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01138605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01138605.